Novotech, an Australia-based CRO, has expanded its relationship with Medidata Solutions, a global provider of cloud-based clinical development solutions, by achieving accreditation for Medidata Rave, a system for electronic data capture (EDC) and clinical data management (CDM).
Novotech joined the Medidata Partner Program in 2010 to support its offering of data management solutions for biotechnology and pharmaceutical clients conducting phase I-III trials, and has since expanded its use of Medidata technology in its clinical trials, including Rave for data management and Medidata Balance for randomization services. Novotech takes advantage of Medidata’s cloud-based technology to streamline and enhance clinical processes for their clients.
Novotech CEO Alek Safarian said its Rave accreditation means Novotech clients can expect further streamlining of EDC delivery from the CRO, using a single data platform across complex regional studies.
“With our partnership expansion, Novotech now combines their deep expertise and best practices for leveraging Medidata’s cloud-based technology to further benefit sponsors’ clinical trials,” said Steve Heath, vice president of channel sales at Medidata Solutions.